Peptides International, Inc. Uroguanylin (Human) (0.1 mg vial) PUG-4295-s - 1 Ea

Description
Asn-Asp-Asp-Cys-Glu- Leu-Cys-Val-Asn-Val- Ala-Cys-Thr-Gly-Cys- Leu (Disulfide bonds between Cys4-Cys12 and Cys7-Cys15) (M.W. 1667.9) C64H102N18O26S4 [154525-25-4] Guanylate Cyclase C Activator T. Kita, C.E. Smith, K.F. Fok, K.L. Duffin, W.M. Moore, P.J. Karabatsos, J.F. Kachur, F.K. Hamra, N.V. Pidhorodeckyj, L.R. Forte, and M.G. Currie, Am. J. Physiol., 266, F342 (1994). (Original) M. Nakazato, H. Yamaguchi, H. Kinoshita, K. Kangawa, H. Matsuo, N. Chino, and S. Matsukura, Biochem. Biophys. Res. Commun., 220, 586 (1996). (Biologically Active/Inactive Isomer) H. Kinoshita, S. Fujimoto, M. Nakazato, N. Yokota, Y. Date, H. Yamaguchi, S. Hisanaga, and T. Eto , Kidney Int., 52, 1028 (1997). (Urine/Plasma Level; Renal Disease) N. Chino, S. Kubo, T. Kitani, T. Yoshida, R. Tanabe, Y. Kobayashi, M. Nakazato, K. Kangawa, and T. Kimura, FEBS Lett., 421, 27 (1998). (Biochem.; Topological Isomers)L.R. Forte and M.G. Currie, FASEB J., 9, 643 (1995). (Review) L.R. Forte, X.H. Fan, and F.K. Hamra, Am. J. Kidney Dis., 28, 296 (1996). (Review)
  • Uroguanylin (Human) (0.1 mg vial) - PUG-4295-s - 1 Ea - Peptides International, Inc.
    Peptides International, Inc.
Description
Asn-Asp-Asp-Cys-Glu- Leu-Cys-Val-Asn-Val- Ala-Cys-Thr-Gly-Cys- Leu (Disulfide bonds between Cys4-Cys12 and Cys7-Cys15) (M.W. 1667.9) C64H102N18O26S4 [154525-25-4] Guanylate Cyclase C Activator T. Kita, C.E. Smith, K.F. Fok, K.L. Duffin, W.M. Moore, P.J. Karabatsos, J.F. Kachur, F.K. Hamra, N.V. Pidhorodeckyj, L.R. Forte, and M.G. Currie, Am. J. Physiol., 266, F342 (1994). (Original) M. Nakazato, H. Yamaguchi, H. Kinoshita, K. Kangawa, H. Matsuo, N. Chino, and S. Matsukura, Biochem. Biophys. Res. Commun., 220, 586 (1996). (Biologically Active/Inactive Isomer) H. Kinoshita, S. Fujimoto, M. Nakazato, N. Yokota, Y. Date, H. Yamaguchi, S. Hisanaga, and T. Eto , Kidney Int., 52, 1028 (1997). (Urine/Plasma Level; Renal Disease) N. Chino, S. Kubo, T. Kitani, T. Yoshida, R. Tanabe, Y. Kobayashi, M. Nakazato, K. Kangawa, and T. Kimura, FEBS Lett., 421, 27 (1998). (Biochem.; Topological Isomers)L.R. Forte and M.G. Currie, FASEB J., 9, 643 (1995). (Review) L.R. Forte, X.H. Fan, and F.K. Hamra, Am. J. Kidney Dis., 28, 296 (1996). (Review)

Suppliers

Company
Product
Description
Supplier Links
Uroguanylin (Human) (0.1 mg vial) - PUG-4295-s - 1 Ea - Peptides International, Inc.
Peptides International, Inc.
Louisville, KY, USA
Uroguanylin (Human) (0.1 mg vial)
PUG-4295-s - 1 Ea
Uroguanylin (Human) (0.1 mg vial) PUG-4295-s - 1 Ea
Asn-Asp-Asp-Cys-Glu- Leu-Cys-Val-Asn-Val- Ala-Cys-Thr-Gly-Cys- Leu (Disulfide bonds between Cys4-Cys12 and Cys7-Cys15) (M.W. 1667.9) C64H102N18O26S4 [154525-25-4] Guanylate Cyclase C Activator T. Kita, C.E. Smith, K.F. Fok, K.L. Duffin, W.M. Moore, P.J. Karabatsos, J.F. Kachur, F.K. Hamra, N.V. Pidhorodeckyj, L.R. Forte, and M.G. Currie, Am. J. Physiol., 266, F342 (1994). (Original) M. Nakazato, H. Yamaguchi, H. Kinoshita, K. Kangawa, H. Matsuo, N. Chino, and S. Matsukura, Biochem. Biophys. Res. Commun., 220, 586 (1996). (Biologically Active/Inactive Isomer) H. Kinoshita, S. Fujimoto, M. Nakazato, N. Yokota, Y. Date, H. Yamaguchi, S. Hisanaga, and T. Eto , Kidney Int., 52, 1028 (1997). (Urine/Plasma Level; Renal Disease) N. Chino, S. Kubo, T. Kitani, T. Yoshida, R. Tanabe, Y. Kobayashi, M. Nakazato, K. Kangawa, and T. Kimura, FEBS Lett., 421, 27 (1998). (Biochem.; Topological Isomers)L.R. Forte and M.G. Currie, FASEB J., 9, 643 (1995). (Review) L.R. Forte, X.H. Fan, and F.K. Hamra, Am. J. Kidney Dis., 28, 296 (1996). (Review)

Asn-Asp-Asp-Cys-Glu-Leu-Cys-Val-Asn-Val-Ala-Cys-Thr-Gly-Cys-Leu (Disulfide bonds between Cys4-Cys12 and Cys7-Cys15) (M.W. 1667.9) C64H102N18O26S4 [154525-25-4] Guanylate Cyclase C Activator T. Kita, C.E. Smith, K.F. Fok, K.L. Duffin, W.M. Moore, P.J. Karabatsos, J.F. Kachur, F.K. Hamra, N.V. Pidhorodeckyj, L.R. Forte, and M.G. Currie, Am. J. Physiol., 266, F342 (1994). (Original) M. Nakazato, H. Yamaguchi, H. Kinoshita, K. Kangawa, H. Matsuo, N. Chino, and S. Matsukura, Biochem. Biophys. Res. Commun., 220, 586 (1996). (Biologically Active/Inactive Isomer) H. Kinoshita, S. Fujimoto, M. Nakazato, N. Yokota, Y. Date, H. Yamaguchi, S. Hisanaga, and T. Eto , Kidney Int., 52, 1028 (1997). (Urine/Plasma Level; Renal Disease) N. Chino, S. Kubo, T. Kitani, T. Yoshida, R. Tanabe, Y. Kobayashi, M. Nakazato, K. Kangawa, and T. Kimura, FEBS Lett., 421, 27 (1998). (Biochem.; Topological Isomers)L.R. Forte and M.G. Currie, FASEB J., 9, 643 (1995). (Review) L.R. Forte, X.H. Fan, and F.K. Hamra, Am. J. Kidney Dis., 28, 296 (1996). (Review)

Supplier's Site

Technical Specifications

  Peptides International, Inc.
Product Category Organic Chemicals
Product Number PUG-4295-s - 1 Ea
Product Name Uroguanylin (Human) (0.1 mg vial)
Unlock Full Specs
to access all available technical data

Similar Products

AsahiKlin Precision Cleaning Solvent - AE3000 - AGC Chemicals Americas, Inc.
AGC Chemicals Americas, Inc.
AsahiKlin Precision Cleaning Solvent
AE3000
Specs
Trigger Solvent
Chemical Family All Halogenated; All Ethers
Chemical Name 1,1,2,2-tetra fluoroethyl-2,2,2-trifluoromethyl ether
View Details
DMI 1,3 Dimethyl-2-Imidazolidinone - - Mitsui Chemicals America, Inc.
Mitsui Chemicals America, Inc.
DMI 1,3 Dimethyl-2-Imidazolidinone
Specs
Trigger Solvent
Chemical Name DMI 1,3 Dimethyl-2-Imidazolidinone
State of Matter Liquid / Solution
View Details
Basic Materials & Chemicals - NCC - LG Chemical of America Inc.
LG Chemical of America Inc.
Basic Materials & Chemicals
NCC
Specs
Chemical Family All Alkenes (optional feature); All Classical Arenes (optional feature); Ethylene / Ethene (optional feature); Propylene / Propene (optional feature); Butadiene (optional feature); Toluene (optional feature)
View Details
Factor XIIIa - 760-4384 - Ventana Medical Systems, Inc.
Ventana Medical Systems, Inc.
Factor XIIIa
760-4384
View Details